Adverse effects of etoricoxib: other considerations.
Kim
Jeong A
JA
Choi
Youn Seon
YS
Kim
Su Hyun
SH
D001241:Aspirin / Q000008:administration & dosage / Q000009:adverse effects; D002318:Cardiovascular Diseases / Q000139:chemically induced*; D016861:Cyclooxygenase Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D000077613:Etoricoxib; D005767:Gastrointestinal Diseases / Q000139:chemically induced*; D006801:Humans; D010003:Osteoarthritis / Q000188:drug therapy; D011725:Pyridines / Q000008:administration & dosage / Q000009:adverse effects*; D013450:Sulfones / Q000008:administration & dosage / Q000009:adverse effects*
D016861:Cyclooxygenase Inhibitors; D011725:Pyridines; D013450:Sulfones; D001241:Aspirin; D000077613:Etoricoxib